Add J. Brandon Dixon

Author: TKassis

output/j-brandon-dixon/SKILL.md

@@ -0,0 +1,82 @@
+---
+name: j-brandon-dixon
+description: Apply the bioengineering, mechanobiology, and lymphatic transport reasoning of J. Brandon Dixon, professor of mechanical and biomedical engineering at Georgia Institute of Technology. Reach for this skill whenever analyzing lymphatic biomechanics, active vessel contractility versus passive drainage, peristaltic fluid transport, microfluidic organ-on-a-chip design, preclinical lymphedema models, non-invasive functional imaging, targeted nanomedicine delivery, or automated disease staging. Use this skill to critique bioengineering assumptions, guide quantitative protocol design, evaluate biomechanical pump failure, and formulate interdisciplinary biomedical solutions.
+---
+
+# Thinking like J. Brandon Dixon
+
+J. Brandon Dixon's work operates at the intersection of biomechanics, fluid dynamics, cell biology, and microfluidics. Rather than viewing vascular systems as simple passive plumbing, Dixon frames self-pumping biological networks—specifically lymphatic collecting vessels—as dynamic, autonomous, cardiac-like muscle pumps. Central to his thinking is the realization that long-term pathological outcomes (such as secondary lymphedema following cancer surgery) stem from biomechanical compensation: intact vessels hyper-pump under elevated afterload, masking acute damage while accumulating oxidative stress, smooth muscle remodeling, and eventual pump failure.
+
+To unravel these complex biofluidic systems, Dixon champions multi-scale engineering integration: coupling high-speed functional imaging, lumped-parameter computational modeling, microfluidic lymphatics-on-a-chip, and user-centered device design. He rigorously privileges active functional performance over static structural presence, demanding tools and models that quantify flow rate, occlusion pressure, and pump metrics rather than vessel counts or histology alone.
+
+Reach for this skill whenever you are designing microfluidic devices, evaluating biofluidic or peristaltic transport systems, modeling vascular mechanobiology, framing preclinical animal disease models, or developing targeted biomedical diagnostics and therapeutics.
+
+## Core principles
+
+- **Compensatory Hyper-Pumping Masks and Accelerates Pump Failure**: Acute surgical or structural loss forces remaining intact vessels to increase contractile frequency and force; this short-term compensation induces long-term oxidative stress, smooth muscle remodeling, and delayed pump breakdown.
+- **Integrate Multidisciplinary Engineering with Mechanobiology**: Elucidating self-pumping vascular systems requires tightly coupling molecular biology, fluid biomechanics, high-speed dynamic imaging, computer signal processing, and computational modeling.
+- **Measure Active Functional Transport, Not Static Architecture**: Diagnostic and therapeutic success must be evaluated by dynamic pumping pressure, clearance velocity, and contractile mechanics rather than structural vessel presence or static staining.
+- **Target Multiple Pathological Pathways Simultaneously**: Chronic secondary diseases involving mechanical pump impairment, tissue fibrosis, and inflammation require combined therapeutics (e.g., pro-lymphangiogenic plus anti-inflammatory agents) rather than single-target magic bullets.
+- **Design In Vitro Systems for Collaborative Simplicity**: Bioengineering platforms and microfluidic microenvironments must be operationally simple enough for non-engineers to independently adopt and replicate.
+
+For detailed rationale and verbatim quotes, see `references/principles.md`.
+
+## How J. Brandon Dixon reasons
+
+When evaluating a biological or bioengineering problem, Dixon first asks: *Is this an active pump or a passive drain, and what mechanical loads are the functional units experiencing?* He rejects pure static structural observations, looking instead at the dynamic balance between fluid shear stress, transmural pressure, and active muscle recruitment.
+
+His primary cognitive framework models lymphangions as chains of autonomous cardiac-like chambers subject to fatigue. When analyzing fluid mechanics in peristaltic systems, he focuses on valve-phase interactions and segmental compression, recognizing that asynchronous valve operation drastically changes volumetric flow. When building platforms, he balances physiological fidelity with operational usability, insisting that a microfluidic tool is useless if non-engineering collaborators cannot run it.
+
+To explore these mental models in detail, see `references/mental-models.md`.
+
+## Applying the frameworks
+
+### Non-Invasive Lymphatic Occlusion Pressure Protocol
+Use when quantifying active vessel pumping performance and functional pressure generation in vivo.
+1. Inject a non-perturbing near-infrared (NIR) fluorescent tracer intradermally into the distal tissue bed.
+2. Place a dynamic occlusion cuff downstream over the target collecting vessel.
+3. Inflate the cuff to a pressure exceeding vessel systolic capability until fluorescence packet movement ceases.
+4. Deflate the cuff incrementally while recording dynamic NIR fluorescence.
+5. Identify the exact cuff pressure at which active contractile packets resume downstream transport.
+
+### Longitudinal Volumetric and Functional Lymphedema Model
+Use when evaluating disease progression or therapeutic efficacy in preclinical models.
+1. Implement a partial-injury surgical model (e.g., single-side vessel ligation) that preserves intact alternative pathways.
+2. Track external tissue swelling over time using non-invasive 3D surface scanning.
+3. Measure active transport metrics (contraction frequency, packet velocity, occlusion pressure) using NIR dynamic imaging.
+4. Correlate functional pump metrics with tissue-level histopathology (fibrosis, epidermal thickening, lipid deposition).
+
+### Lumped Parameter Mechanobiological Adaptation Model
+Use when computationally simulating vascular pump adaptation under altered mechanical loading.
+1. Represent lymphangion segments using lumped circuit parameters coupled with active contractile dynamics.
+2. Integrate short-term vasoreactive feedback driven by fluid wall shear stress.
+3. Apply constitutive growth equations driven by transmural pressure and circumferential stress to predict structural wall remodeling and pump failure.
+
+For the complete computational and protocol details, see `references/frameworks.md`.
+
+## Anti-patterns they push against
+
+- **Exclusively Using Complete Ablation/Ligation Animal Models**: Completely severing all drainage pathways eliminates partial flow, altered pressure gradients, and hyper-pumping compensation seen in human patients.
+- **Over-Engineering Bespoke Microfluidics**: Building overly complex microfluidic chips that non-engineering biological collaborators cannot operate without expert assistance.
+- **Treating NIR Tracers as Inert Molecules**: Ignoring how diagnostic contrast dyes (e.g., ICG) can alter fluid load or temporarily suppress intrinsic vessel contractility.
+- **Setting Integer Valve Spacing Ratios**: Spacing valves at exact integer multiples of the contraction wavelength ($L = 1, 2$), which causes synchronous opening and eliminates volumetric pumping.
+- **Evaluating Interventions Solely on Short-Term Recovery**: Judging surgical or therapeutic success immediately post-injury, ignoring long-term mechanical strain that causes pump failure years later.
+
+For the complete catalog with full rationale and quotes, see `references/anti-patterns.md`.
+
+## Heuristics and rules of thumb
+
+- **The 2/3 Valve Spacing Rule**: Set the ratio of inter-valve spacing to peristaltic contraction wavelength to approximately $2/3$ ($L \approx 0.67$) to maximize volumetric pumping efficiency.
+- **The Early Intervention Window**: Apply pump-enhancing therapeutics while tissue swelling is mild ($<25\%$) before irreversible fibrosis and smooth muscle fatigue develop.
+- **The Non-Engineer Adoption Test**: If a biological collaborator cannot independently run your microfluidic device after one demonstration, simplify the design.
+- **Tracer Volume Control**: Keep intradermal tracer injection volumes minimal to avoid artificially inducing elevated pressure or contractility artifacts.
+
+For additional heuristics and source attribution, see `references/heuristics.md`.
+
+## How to use this skill in conversation
+
+When assisting with bioengineering, mechanobiology, or diagnostic design problems:
+- **Frame functional failure through biomechanical adaptation**: Explain how early hyper-pumping or compensation can hide progressive cellular fatigue and structural failure.
+- **Focus on dynamic functional metrics over static images**: Direct users to measure flow velocity, occlusion pressure, or contractile frequency rather than relying purely on vessel counts or histological staining.
+- **Critique over-complicated devices**: Push back on microfluidic or experimental designs that trade operational robustness for unnecessary complexity.
+- **Cite Dixon's models directly**: Refer explicitly to Dixon's concepts (e.g., "J. Brandon Dixon's concept of the lymphatic vessel as an intrinsic cardiac-like pump" or "Dixon's 2/3 valve spacing ratio for peristaltic pumping"). Do not impersonate him—apply his principles with analytical rigor.

output/j-brandon-dixon/references/anti-patterns.md

@@ -0,0 +1,36 @@
+# Anti-Patterns Identified by J. Brandon Dixon
+
+Common pitfalls, flawed assumptions, and improper experimental designs explicitly warned against by J. Brandon Dixon.
+
+## Relying Exclusively on Complete Circumferential Ligation Models
+Using preclinical animal models that perform 360-degree surgical excision of all lymphatic vessels and nodes.
+*Why it fails*: Complete obstruction eliminates intact alternative pathways, preventing researchers from observing the fluid shear, altered pressure gradients, and compensatory hyper-pumping that occur in human lymphedema patients.
+(sources: src_010)
+
+## Designing Overly Complex Bespoke Microfluidics
+Engineering complex, highly specialized microfluidic chips that require constant expert engineering intervention to operate.
+*Why it fails*: Overly intricate systems become single-use academic publications that are never adopted by biological labs or translational clinicians.
+> "ninety percent I guess means devices never use again because they're super complicated..."
+(sources: src_009)
+
+## Assuming Functional Contrast Tracers Are Biologically Inert
+Treating intradermal fluorescent dyes (e.g., Indocyanine Green) as completely passive indicators during longitudinal functional imaging.
+*Why it fails*: Contrast agents can persist in tissues for days and transiently suppress intrinsic smooth muscle contractility, distorting longitudinal transport calculations if uncorrected.
+> "you can't have to be really careful when you're trying to analyze data and say what's happening over time when your technique itself"
+(sources: src_009)
+
+## Integer Multiple Valve Spacing in Peristaltic Pumping Systems
+Configuring elastic one-way valves at exact integer multiples of the peristaltic contraction wavelength ($L = 1, 2, \dots$).
+*Why it fails*: Integer spacing causes consecutive valves to open and close synchronously, eliminating cyclic volume changes within vessel segments and drastically reducing pumping efficiency against pressure heads.
+(sources: src_026)
+
+## Evaluating Surgical Interventions Solely on Short-Term Acute Recovery
+Assessing tissue health or surgical success immediately after surgical node/vessel removal without long-term follow-up.
+*Why it fails*: Remaining intact vessels hyper-pump initially to mask tissue injury, but chronic oxidative stress causes secondary vessel degeneration and pump breakdown years later.
+> "During the procedure, some of the lymphatic vasculature is taken out because the surgeon is almost operating blind. If the lymphatic system suffers from injury during surgery, the damage is often difficult to gauge, presenting as lymphedema maybe two to five years later"
+(sources: src_017)
+
+## Using Standard Frame-Rate Video Microscopy for Peak Microlymphatic Flow
+Relying on standard video camera frame rates ($30\text{ fps}$) to calculate peak microlymphatic flow velocity during fast contraction cycles.
+*Why it fails*: Standard video rates fail to capture flow speeds exceeding $\sim 3.75\text{ mm/s}$, significantly underestimating true peak contraction velocities (which reach up to $7\text{ mm/s}$).
+(sources: src_020)

output/j-brandon-dixon/references/frameworks.md

@@ -0,0 +1,36 @@
+# Frameworks of J. Brandon Dixon
+
+Detailed steps and protocols developed by J. Brandon Dixon for biomechanical modeling, functional imaging, and preclinical testing.
+
+## Non-Invasive Lymphatic Occlusion Pressure Measurement
+In vivo diagnostic protocol using near-infrared fluorescent imaging and a dynamic occlusion cuff to quantify active pumping pressure and functional recovery.
+
+### Protocol Steps:
+1. **Tracer Administration**: Inject a small, non-perturbing volume of near-infrared fluorescent tracer (e.g., ICG conjugated to serum albumin or nanocarriers) intradermally in the distal tissue bed.
+2. **Cuff Positioning**: Place a custom inflatable occlusion cuff downstream over the target collecting vessel.
+3. **Complete Occlusion**: Inflate the cuff to a baseline pressure sufficient to collapse the vessel lumen completely, halting forward movement of fluorescent packets.
+4. **Gradual Deflation**: Stepwise deflate cuff pressure while continuously recording dynamic near-infrared fluorescence at high frame rates.
+5. **Threshold Identification**: Determine the exact pressure threshold at which active contractile packets overcome cuff resistance and resume downstream transport.
+> "we inject a near-infrared tracer we see the lymphatic then we inflate this occlusion cuff right here to a level that completely um collapses the vessel and wait for the fluorescence to empty out then we gradually deflate the pressure in the cuff and then we can determine the pressure at which we see restoration of flow"
+(sources: src_009, src_010)
+
+## Longitudinal Volumetric and Functional Lymphedema Assessment
+Preclinical protocol combining non-invasive 3D surface scanning with dynamic NIR imaging to track disease initiation, progression, and therapeutic responses over time.
+
+### Protocol Steps:
+1. **Clinically Relevant Injury**: Perform partial surgical node/vessel dissection or single-side vessel ligation combined with localized radiation, leaving intact alternative pathways.
+2. **3D Surface Scanning**: Perform regular non-invasive 3D limb surface acquisition (e.g., handheld or mobile LiDAR scanning) to quantify volume changes and swelling percentage over baseline.
+3. **Dynamic NIR Functional Imaging**: Quantify active pumping parameters—including contraction frequency, packet speed, stroke volume index, and occlusion pressure—at regular longitudinal timepoints.
+4. **Histopathological Correlation**: Match long-term functional loss with tissue-level histopathology, evaluating epidermal thickness, collagen alignment, and subcutaneous fat expansion.
+> "To characterize lymphatic alterations and their association with disease pathology in a clinically relevant model in the rat, we developed a longitudinal iPhone-based volumetry method combined with non-invasive NIR analysis of lymphatic function."
+(sources: src_021)
+
+## Lumped Parameter Mechanobiological Adaptation Framework
+Computational framework modeling lymphangion fluid dynamics, active/passive wall mechanobiology, and structural growth laws under acute and chronic mechanical loads.
+
+### Computational Steps:
+1. **Lymphangion Fluid Dynamics**: Model individual lymphangion segments using lumped circuit parameters coupled with active smooth muscle contraction models and passive wall constitutive equations.
+2. **Acute Vasoreactive Feedback**: Incorporate short-term feedback functions driven by fluid wall shear stress and transmural pressure to model acute vasomotion and tone adjustments.
+3. **Chronic Structural Growth**: Implement constitutive growth laws driven by sustained wall hoop stress and pressure overload to calculate volumetric wall thickening, loss of elastic compliance, and eventual pump failure.
+> "This theoretical framework combines a simplified version of a published lumped parameter model for lymphangion function and lymph transport, a published microstructurally motivated constitutive model for the active and passive mechanical behavior of isolated rat thoracic ducts, and novel models for acute mechanically mediated vasoreactive adaptations and long-term volumetric growth..."
+(sources: src_018)

output/j-brandon-dixon/references/heuristics.md

@@ -0,0 +1,21 @@
+# Heuristics and Rules of Thumb of J. Brandon Dixon
+
+Practical guidelines and rules of thumb applied by J. Brandon Dixon across bioengineering device design, imaging, and preclinical experimentation.
+
+## Optimal Valve Spacing Ratio for Peristaltic Efficiency
+Set the ratio of inter-valve spacing ($L$) to peristaltic contraction wavelength ($\lambda$) to approximately $2/3$ ($L/\lambda \approx 0.67$) when designing or analyzing valved peristaltic pumping networks. This ratio maximizes the duration of asynchronous valve opening, optimizing volumetric pumping against adverse pressure gradients.
+> "The optimum pumping occurs when the ratio of valve spacing to contraction wavelength is about 2/3."
+(sources: src_026)
+
+## Early Intervention Window for Pump-Enhancing Therapeutics
+Apply active pump-stimulating or pro-lymphangiogenic therapies while tissue edema is mild (limb volume increase $<25\%$). Once chronic swelling induces extensive tissue fibrosis and muscle atrophy, intrinsic pump restoration alone is insufficient.
+(sources: src_010)
+
+## The Collaborative Adoption Rule for Microfluidic Design
+If a microfluidic platform or organ-on-a-chip device cannot be independently set up and operated by a biological or clinical collaborator after minimal instruction, simplify the platform design.
+(sources: src_009)
+
+## Tracer Volume and Artifact Control in Functional NIR Imaging
+Keep intradermal contrast agent volumes and concentrations as low as possible during dynamic NIR imaging. Excess tracer volume increases interstitial fluid pressure and can alter intrinsic vessel contraction frequency, creating measurement artifacts over longitudinal studies.
+> "you can't have to be really careful when you're trying to analyze data and say what's happening over time when your technique itself"
+(sources: src_009)